Neurology News

A validated score was able to predict among which patients with epilepsy stereoelectroencephalography was unlikely to identify a focal seizure-onset zone, according to results of a cohort study published in JAMA Neurology.

Increased sunlight exposure may offer significant protection against development of pediatric MS, according to study results published in Neurology.

Researchers identified four characteristics that were likely to improve a physician’s trust in their organization.

A single-arm, single-blind, phase 2a study of the neuromodulating drug RL-007, initiated by biopharmaceutical company atai Life Sciences, revealed its effectiveness in improving cognitive function and awareness in patients with schizophrenia.

Biogen Inc. and TheraPanacea announced a collaboration to use machine learning and artificial intelligence analysis to develop digital health solutions for neurological diseases, according to a company press release.

Patients who present with a low Alberta Stroke Program Early Computed Tomography Score may achieve functional independence following mechanical thrombectomy, according to results of a retrospective cohort study.

Post-acute sequelae of COVID-19 impacted nonhospitalized patients with MS, according to results of a prospective and longitudinal cohort study published in Neurology: Neuroimmunology & Neuroinflammation.

The FDA has granted orphan drug designation to NeurOp Inc. for an investigational candidate for treating subarachnoid hemorrhage, according to a company press release.

During the COVID-19 pandemic, physicians of all specialties have demonstrated a renewed focus on long-term financial and life goals.

Extracardiac anomalies, including structural brain anomalies, were frequently detected on fetal MRI among fetuses with various forms of congenital heart disease, researchers reported.